Drug substance development for smoking cessation On September 1st, 2023, TBD Pharmatech started together with the Latvian Institute of Organic Synthesis a new project PharmaBoost – EstLat Alliance…
Read moreA study co-authored by TBD and published in “Pharmaceuticals” in August 2023 has detailed the properties and potential applications in metal-free click chemistry for a new compound, tetramethylthiocycloheptyne…
Read moreTBD believes that community engagement and sportsmanship go hand in hand in fostering a vibrant, healthy work environment. The company takes immense pride in supporting its women’s volleyball…
Read more
First Foray into Disc Golf In September last year, TBD Pharmatech plunged into the unfamiliar world of disc golf. Our debut team – Sander Kotkas, Jürgen Vahter, and Merle Muruvee – represented…
Read moreThe project aims to develop a new, more effective technology for synthesizing an active pharmaceutical ingredient (API) for a drug used primarily as a pain reliever for moderate to severe pain. The…
Read more
On March 20, 2023, TBD Pharmatech proudly hosted the bright minds of BÜS – a student organization from Tartu University that unites natural sciences students. BÜS aims to empower future biologists…
Read more
Ravimainete arendaja ja tootja, mis pakub peenkeemia lahendusi farmaatsia- ja biotehnoloogia ettevõttetele.
